Tag Archives: Insights

Safety Net Provides a Win-Win: Why the NCAA’s Proposal to Change the NBA Draft Rules is an Overdue Improvement

NICOLE COMPARATO—As college basketball season returns and fans’ favorite teams take the hardwood, there will undoubtedly be murmurs about the players who entered the NBA Draft foregoing their remaining years of eligibility. Fans will especially lament those players who went undrafted or remain unsigned by NBA teams when they could have been continuing their college […]

California’s Bacon: The Legal Ramifications of the New WHO Study

A Controversial Study BETH COPLOWITZ—On October 26, 2015, the World Health Organization (WHO) released a study in The Lancet Oncology stating that red and processed meats may cause cancer.  The study was published by the International Agency for Research on Cancer (IARC), the agency within the WHO that conducts research into the causes of cancer […]

Do Artists Have Real Copyright Protection Against Political Candidates Using Their Songs on the Campaign Trail, or Should We ‘Dream On’?

PAIGE COMPARATO—In mid-October, Steven Tyler of Aerosmith sent a cease-and-desist letter to Republican Presidential Candidate Donald Trump asking him to stop playing the band’s song “Dream On” at campaign events. The letter stated that the candidate did not have permission to use the song, and “it gives the false impression that [Tyler] is connected with […]

Recreational Drone Regulation: Is the Free-For-All Coming to an End?

ANNIE BRETT—Recreational drone use has exploded in recent years, rising to over 700,000 unit sales in 2015 alone. While this rise has enabled the general public to explore and utilize the nation’s airspace for the first time, concerns have grown about the safety of widespread drone use. Airplane pilots regularly report interference from drones during […]

Medication and American Capitalism: Has the Need for Regulating Medication Prices Reached the Doorsteps of the Drug Industry?

Name Your Price: Daraprim Experiences an Up-pricing JEAN PHILLIP SHAMI—With one purchase in August 2015, a 62-year-old drug used to treat a rare and deadly infection called toxoplasmosis experienced a drastic 5,000% price increase from $13.50 a pill to $750 a pill. Daraprim, which AIDS/HIV patients often take because of weakened immune systems, became the […]